247 results
Page 3 of 13
8-K
EX-99.1
wrux2kev78wpej
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-99.1
esktt5kaxbvb8o
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.3
22hvlf1 zg85c
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
EX-99
2gw5x
30 Sep 20
Third party tender offer statement (amended)
8:06am
8-K
EX-10.4
lgvsdhywibklm 60t
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
4bk7v8flk z5
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
bgiqb d2lrdf
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
zyqe w54hb33dxcrhw18
10 Aug 20
Information about tender offer
9:52pm
8-K
EX-99.1
g94 pun0nsoe
3 Aug 20
Ligand Reports Second Quarter 2020 Financial Results
7:48am
8-K
EX-99.1
cabf2
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
1xc5p
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
u3xx 8fme
11 Feb 20
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
4:28pm
8-K
EX-99.1
oh4roh7 na9
6 Feb 20
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
EX-99.1
poc75zxat5s
5 Nov 19
Ligand Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
lxw7txcg9a0bkotg7p
30 Jul 19
Ligand Reports Second Quarter 2019 Financial Results
8:13am